동물 정형외과 시장 : 제품별, 동물 유형별, 용도별, 재료별, 최종사용자별, 지역별 - 세계 예측(-2031년)

The veterinary orthopedics market is expected to grow from USD 0.57 billion in 2026 to USD 0.86 billion by 2031, at a CAGR of 8.5%. This growth is driven by several key factors shaping the future of veterinary orthopedic care, surgical intervention, and mobility restoration in animals.

The key factor driving this market is the rising incidence of musculoskeletal disorders, trauma, and degenerative joint diseases in companion and livestock animals, as well as the growing willingness of pet owners to opt for advanced orthopedic procedures. With the steady evolution of veterinary care toward greater specialization and results-oriented care, there is a growing demand for superior orthopedic implants, fixation devices, and procedure-oriented surgical solutions. Veterinary hospitals and specialty practices are seeking innovative solutions to improve surgical accuracy, recovery time, and post-surgical mobility.

In addition, the increasing prevalence of age-related orthopedic diseases, joint diseases in obese patients, and trauma-related cases is increasing the need for effective, reliable, and standardized orthopedic procedures. Advanced fixation devices, joint stabilizing, and reconstructive products are important in meeting this need. Increased referrals and specialized orthopedic practices are also fueling growth in procedures. Current modernization trends in the veterinary health sector, such as advancements in imaging, digital surgical planning, and post-operative rehabilitative care, are also driving increased adoption of advanced solutions in the orthopedic space. A growing emphasis on surgeon education and evidence-based best practices is further improving adoption rates.

Advances in the veterinary orthopedics market, driven by technological developments such as enhanced biomaterials and patient-specific devices, minimally invasive procedures, and 3D-printed surgical guides, are propelling the market forward. Enhancements in the quality and ease of usage of devices will contribute to the growth of the veterinary orthopedics market during the forecasted period.

"By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period."

Dogs and cats are more prone to orthopedic disorders, such as ligament tears, fractures, and joint disorders, due to aging or obesity; hence, there is a constant demand for these products. Further, the easy accessibility of specialty animal hospitals, the growing awareness among owners of the outcomes of these procedures, and the gradually increasing adoption rate of pet insurance plans are also supporting this growth.

"By end user, the veterinary hospitals & clinics segment accounted for the largest market share in 2025."

In 2025, the veterinary hospitals & clinics segment dominated the veterinary orthopedics market as they are the primary locations for diagnosis and surgical and post-surgical follow-up treatments for orthopedic disorders in animals. The number of trauma cases, ligament injuries, and degenerative joint disorders treated by veterinary hospitals and clinics remains high, and they are increasingly set up with highly sophisticated surgical facilities and orthopedic capabilities. Moreover, the increased development of multi-specialty veterinary hospitals and the in-house approach to orthopedic care, rather than referral orthopedic care, are responsible for increased use within veterinary hospitals and clinics.

"The Asia Pacific region is expected to witness the highest growth rate during the forecast period."

The Asia Pacific region is likely to report the highest CAGR in the veterinary orthopedics market. This is due to the accelerated growth in the number of pet owners and continued increases in expenditure on animal care in countries such as China, India, Japan, and Australia. The improvement in veterinary infrastructure, with the development of orthopedic specialty hospitals and referral centers, is creating greater access to diagnostic work-ups and surgeries. Further, the growing recognition of the role of mobility in quality of life, along with the availability of orthopedic surgeons and the increased availability of pet insurance, is fueling the uptake of surgical procedures.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
• By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

• By End User: Veterinary Hospitals & Clinics (45%), Specialty Orthopedic Clinics (24%), Emergency Animal Hospitals (14%), Academic & Research Institutes (10%), and Animal Rehabilitation Centers (7%)

By Designation: Veterinarians (47%), Veterinary Hospital Directors & Managers (22%), Veterinary Critical Care Specialists (15%), and Others (16%)

• By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Research Coverage

The market study covers the veterinary orthopedics market in various segments. It aims to estimate the market size and growth potential by product, material, animal type, application, end user, and region. The study also includes an in-depth competitive analysis of the market's key players, along with their company profiles, key observations on their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger share of the market. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

• Analysis of key drivers (rising companion animal ownership & spending on pet healthcare, higher incidence of orthopedic conditions, and growth in specialty veterinary hospitals & referral networks with advanced surgical capabilities and technology improvements in implants and instruments), restraints (high cost of orthopedic implants, instruments, and advanced surgical procedures and limited availability of trained veterinary orthopedic surgeons), opportunities (geographic expansion into emerging markets and growing adoption of patient-specific implants and 3d-printed guides), and challenges (clinical outcome variability and complication risk and regulatory and quality compliance across regions) influencing the growth of the veterinary orthopedics market.
• Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the veterinary orthopedics market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary orthopedic products across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary orthopedics market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary orthopedics market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 MARKET STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS IN VETERINARY ORTHOPEDICS MARKET
• 2.4 HIGH-GROWTH SEGMENTS
• 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 VETERINARY ORTHOPEDICS MARKET OVERVIEW
• 3.2 ASIA PACIFIC: VETERINARY ORTHOPEDICS MARKET, BY PRODUCT & COUNTRY (2025)
• 3.3 VETERINARY ORTHOPEDICS MARKET: REGIONAL MIX
• 3.4 VETERINARY ORTHOPEDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 3.5 VETERINARY ORTHOPEDICS MARKET: DEVELOPED VS. EMERGING ECONOMIES

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rising companion animal ownership and spending on pet healthcare
    • 4.2.1.2 Higher incidence of orthopedic conditions
    • 4.2.1.3 Growth in specialty veterinary hospitals & referral networks with advanced surgical capabilities
    • 4.2.1.4 Technology improvements in implants and instruments
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 High cost of orthopedic implants, instruments, and advanced surgical procedures
    • 4.2.2.2 Limited availability of trained veterinary orthopedic surgeons
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Geographic expansion into emerging markets
    • 4.2.3.2 Growing adoption of patient-specific implants and 3D-printed guides
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Clinical outcome variability and complication risk
    • 4.2.4.2 Regulatory and quality compliance across regions
• 4.3 UNMET NEEDS & WHITE SPACES
  • 4.3.1 UNMET NEEDS IN VETERINARY ORTHOPEDICS MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
  • 4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF SUPPLIERS
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS & FORECAST
  • 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
  • 5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY
• 5.3 SUPPLY CHAIN ANALYSIS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 PRICING ANALYSIS
  • 5.6.1 AVERAGE SELLING PRICE TREND OF VETERINARY ORTHOPEDIC PRODUCTS, BY KEY PLAYER, 2023-2025
    • 5.6.1.1 Average selling price trend of veterinary orthopedic plates, by key player, 2023-2025
    • 5.6.1.2 Average selling price trend of veterinary orthopedic screws, by key player, 2023-2025
    • 5.6.1.3 Average selling price trend of veterinary orthopedic instruments, by key player, 2023-2025
    • 5.6.1.4 Average selling price trend of veterinary orthopedic consumables, by key player, 2023-2025
  • 5.6.2 AVERAGE SELLING PRICE TREND OF VETERINARY ORTHOPEDIC PRODUCTS, BY MATERIAL TYPE, 2023-2025
    • 5.6.2.1 Average selling price trend of metallic veterinary orthopedic products, by type, 2023-2025
    • 5.6.2.2 Average selling price trend of absorbable veterinary orthopedic products, by type, 2023-2025
  • 5.6.3 AVERAGE SELLING PRICE TREND OF VETERINARY ORTHOPEDIC PRODUCTS, BY REGION, 2023-2025
    • 5.6.3.1 Average selling price trend of compression plates, by region, 2023-2025
    • 5.6.3.2 Average selling price trend of locking plates, by region, 2023-2025
    • 5.6.3.3 Average selling price trend of locking screws, by region, 2023-2025
    • 5.6.3.4 Average selling price trend of drilling systems, by region, 2023-2025
    • 5.6.3.5 Average selling price trend of cutting tools, by region, 2023-2025
• 5.7 TRADE ANALYSIS
  • 5.7.1 TRADE DATA FOR HS CODE 9021
    • 5.7.1.1 Import data for HS Code 9021
    • 5.7.1.2 Export data for HS Code 9021
  • 5.7.2 TRADE DATA FOR HS CODE 9018
    • 5.7.2.1 Import data for HS Code 9018
    • 5.7.2.2 Export data for HS Code 9018
• 5.8 KEY CONFERENCES & EVENTS, 2026-2027
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.10 INVESTMENT & FUNDING SCENARIO
• 5.11 SUCCESS STORIES & REAL-WORLD APPLICATIONS
  • 5.11.1 PATIENT-SPECIFIC 3D-PRINTED IMPLANTS FOR COMPLEX CANINE LIMB RECONSTRUCTION
  • 5.11.2 ADVANCED FRACTURE FIXATION IN SMALL ANIMALS USING MODERN ORTHOPEDIC IMPLANT SYSTEMS
  • 5.11.3 LONG-TERM CLINICAL OUTCOMES OF ADVANCED ORTHOPEDIC SURGICAL INTERVENTIONS IN COMPANION ANIMALS
• 5.12 IMPACT OF 2025 US TARIFFS ON VETERINARY ORTHOPEDICS MARKET
  • 5.12.1 INTRODUCTION
  • 5.12.2 KEY TARIFF RATES
  • 5.12.3 PRICE IMPACT ANALYSIS
  • 5.12.4 IMPACT ON COUNTRY/REGION
    • 5.12.4.1 North America
    • 5.12.4.2 Asia Pacific
    • 5.12.4.3 Europe
    • 5.12.4.4 Latin America
  • 5.12.5 IMPACT ON END-USE INDUSTRIES
    • 5.12.5.1 Veterinary hospitals & clinics
    • 5.12.5.2 Specialty orthopedic clinics
    • 5.12.5.3 Emergency animal hospitals
    • 5.12.5.4 Academic & research institutes
    • 5.12.5.5 Animal rehabilitation centers

6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION

• 6.1 TECHNOLOGY ANALYSIS
  • 6.1.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1.1 Patient-specific 3D printing
    • 6.1.1.2 Minimally invasive orthopedic techniques
    • 6.1.1.3 Bioresorbable/Biodegradable implants
  • 6.1.2 COMPLEMENTARY TECHNOLOGIES
    • 6.1.2.1 C-arm/Fluoroscopy & cone-beam CT units
    • 6.1.2.2 On-site bone printing/Bone glue-gun approaches
  • 6.1.3 ADJACENT TECHNOLOGIES
    • 6.1.3.1 Small animal prosthetics and orthoses
    • 6.1.3.2 Implant surface engineering and coatings
• 6.2 TECHNOLOGY/PRODUCT ROADMAP
  • 6.2.1 NEAR TERM (2025-2027)
  • 6.2.2 MID TERM (2028-2030)
  • 6.2.3 LONG TERM (2030+)
• 6.3 PATENT ANALYSIS
  • 6.3.1 PATENT PUBLICATION TRENDS FOR VETERINARY ORTHOPEDICS
  • 6.3.2 JURISDICTION & TOP APPLICANT ANALYSIS
• 6.4 FUTURE APPLICATIONS
  • 6.4.1 PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS AND SURGICAL GUIDES
  • 6.4.2 MINIMALLY INVASIVE AND IMAGE-GUIDED ORTHOPEDIC SURGERY
  • 6.4.3 REGENERATIVE AND BIOLOGICS-ENHANCED ORTHOPEDIC THERAPIES
  • 6.4.4 DIGITAL SURGICAL PLANNING AND AI-ASSISTED DECISION SUPPORT
  • 6.4.5 INTEGRATED REHABILITATION, MOBILITY TRACKING, AND LONG-TERM OUTCOME MANAGEMENT
• 6.5 IMPACT OF AI/GENERATIVE AI ON VETERINARY ORTHOPEDICS MARKET
  • 6.5.1 INTRODUCTION
  • 6.5.2 MARKET POTENTIAL IN VETERINARY ORTHOPEDICS ECOSYSTEM
  • 6.5.3 AI USE CASES
  • 6.5.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY ORTHOPEDICS MARKET

7 SUSTAINABILITY & REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS & COMPLIANCE
  • 7.1.1 REGULATORY ANALYSIS
  • 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.3 INDUSTRY STANDARDS
• 7.2 SUSTAINABILITY INITIATIVES
  • 7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY ORTHOPEDIC PRODUCTS
  • 7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
  • 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 KEY STAKEHOLDERS & BUYING CRITERIA
  • 8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.1.2 BUYING CRITERIA
• 8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
  • 8.2.1 DECISION-MAKING PROCESS
  • 8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.2.4 MARKET PROFITABILITY

9 VETERINARY ORTHOPEDICS MARKET, BY PRODUCT

• 9.1 INTRODUCTION
• 9.2 IMPLANTS
  • 9.2.1 PLATES
    • 9.2.1.1 Global volume analysis of plates, 2024-2031 (thousand units)
    • 9.2.1.2 Compression plates
      • 9.2.1.2.1 Continued preference for absolute stability in simple fractures to drive steady demand for compression plates
    • 9.2.1.3 Locking plates
      • 9.2.1.3.1 Growing cases of biologically challenged fractures and osteotomies to propel locking plate adoption
    • 9.2.1.4 T-plates
      • 9.2.1.4.1 Procedure-critical role of T-plates in distal limb fractures to maintain high adoption rates
    • 9.2.1.5 L-plates
      • 9.2.1.5.1 Growing need for stable corner and juxta-articular fixation to support L-plate adoption
    • 9.2.1.6 Other plates
  • 9.2.2 SCREWS
    • 9.2.2.1 Global volume analysis of screws, 2024-2031 (thousand units)
    • 9.2.2.2 Locking screws
      • 9.2.2.2.1 Locking screws to gain structural preference as absolute stability becomes critical in complex fractures
    • 9.2.2.3 Cortical screws
      • 9.2.2.3.1 Broad clinical utility and low unit cost to boost market
  • 9.2.3 PINS, WIRES, AND NAILS
    • 9.2.3.1 Simple fracture prevalence and cost efficiency to anchor demand for pins, wires, and nails
    • 9.2.3.2 Global volume analysis of pins, wires, and nails, 2024-2031 (thousand units)
  • 9.2.4 EXTERNAL FIXATORS
    • 9.2.4.1 Complex, high-risk fracture management to sustain demand for external fixators
    • 9.2.4.2 Global volume analysis of external fixators, 2024-2031 (thousand units)
• 9.3 INSTRUMENTS
  • 9.3.1 DRILLING SYSTEMS
    • 9.3.1.1 Complex, high-risk orthopedic procedures to sustain demand for advanced drilling systems
  • 9.3.2 CUTTING TOOLS
    • 9.3.2.1 Complex orthopedic reconstructions to drive demand for precision cutting instruments
  • 9.3.3 SURGICAL POWER TOOLS
    • 9.3.3.1 Rising demand for precision, efficiency, and high-throughput orthopedic procedures to drive adoption of surgical power tools
  • 9.3.4 ARTHROSCOPY EQUIPMENT
    • 9.3.4.1 Rising adoption of minimally invasive joint diagnosis and treatment to drive demand for arthroscopy equipment
• 9.4 CONSUMABLES
  • 9.4.1 SUTURES
    • 9.4.1.1 Increasing orthopedic surgical volumes and demand for high-performance wound closure to drive growth of veterinary sutures
    • 9.4.1.2 Global volume analysis of sutures, 2024-2031 (thousand units)
  • 9.4.2 BONE GRAFT MATERIALS
    • 9.4.2.1 Increasing need for bone regeneration and defect reconstruction to drive demand for veterinary bone graft materials
    • 9.4.2.2 Global volume analysis of bone graft materials, 2024-2031 (thousand units)
  • 9.4.3 ORTHOBIOLOGICS
    • 9.4.3.1 Rising adoption of regenerative and minimally invasive therapies to drive demand for veterinary orthobiologics
    • 9.4.3.2 Global volume analysis of orthobiologics, 2024-2031 (thousand units)

10 VETERINARY ORTHOPEDICS MARKET, BY MATERIAL

• 10.1 INTRODUCTION
• 10.2 METALLIC
  • 10.2.1 GLOBAL VOLUME ANALYSIS OF METALLIC IMPLANTS, 2024-2031 (THOUSAND UNITS)
  • 10.2.2 TITANIUM
    • 10.2.2.1 Superior biocompatibility and load-bearing performance to drive adoption of titanium implants in veterinary orthopedics
  • 10.2.3 STAINLESS STEEL
    • 10.2.3.1 Cost-effective strength and structural reliability to sustain demand for stainless steel implants in veterinary orthopedics
• 10.3 ABSORBABLE
  • 10.3.1 GLOBAL VOLUME ANALYSIS OF ABSORBABLE IMPLANTS, 2024-2031 (THOUSAND UNITS)
  • 10.3.2 POLYMER
    • 10.3.2.1 Preference for gradual load transfer and reduced need for secondary surgery supporting polymer-based implants
  • 10.3.3 MAGNESIUM
    • 10.3.3.1 Advancements in biodegradable magnesium alloys to support adoption in veterinary orthopedic fixation
  • 10.3.4 COMPOSITE BIOABSORBABLE MATERIALS
    • 10.3.4.1 Demand for enhanced mechanical strength with biological osteoconductivity to drive adoption of composite bioabsorbable materials

11 VETERINARY ORTHOPEDICS MARKET, BY ANIMAL TYPE

• 11.1 INTRODUCTION
• 11.2 COMPANION ANIMALS
  • 11.2.1 DOGS
    • 11.2.1.1 High incidence of stifle joint disorders and advanced surgical adoption to drive demand for canine orthopedic implants
  • 11.2.2 CATS
    • 11.2.2.1 Routine surgical fixation of feline fractures and miniaturized implant innovation to support market growth
  • 11.2.3 HORSES
    • 11.2.3.1 High lameness burden and arthroscopy-led precision surgery to drive demand for equine orthopedic systems
  • 11.2.4 OTHER COMPANION ANIMALS
• 11.3 LIVESTOCK ANIMALS
  • 11.3.1 CATTLE
    • 11.3.1.1 High lameness prevalence and field-based fracture management needs to drive demand for large-animal orthopedic fixation systems
  • 11.3.2 PIGS
    • 11.3.2.1 Lameness-driven productivity to support orthopedic intervention in swine
  • 11.3.3 POULTRY
    • 11.3.3.1 High prevalence of growth-related skeletal disorders and welfare-driven intervention in high-value birds to drive demand
  • 11.3.4 OTHER LIVESTOCK ANIMALS

12 VETERINARY ORTHOPEDICS MARKET, BY APPLICATION

• 12.1 INTRODUCTION
• 12.2 JOINT REPLACEMENT
  • 12.2.1 TOTAL HIP REPLACEMENT
    • 12.2.1.1 Advancements in implant technology and surgical techniques to drive growth in total hip replacement
  • 12.2.2 TOTAL KNEE REPLACEMENT
    • 12.2.2.1 Enhanced functional outcomes and reduced recovery time to fuel demand for total knee replacement in veterinary orthopedics
  • 12.2.3 TOTAL ELBOW REPLACEMENT
    • 12.2.3.1 Innovative prosthetics and improved surgical approaches to drive growth
• 12.3 TRAUMA FIXATION
  • 12.3.1 FRACTURE REPAIR
    • 12.3.1.1 Technological advancements in fracture repair materials and methods to enhance healing times and patient recovery
  • 12.3.2 LIGAMENT RECONSTRUCTION
    • 12.3.2.1 Minimally invasive techniques and advanced materials to accelerate ligament reconstruction procedures
  • 12.3.3 BONE DEFORMITY CORRECTION
    • 12.3.3.1 Emerging surgical techniques and advanced implants to favor market growth
• 12.4 SPECIFIC PROCEDURES
  • 12.4.1 TIBIAL PLATEAU LEVELING OSTEOTOMY (TPLO)
    • 12.4.1.1 Reduced recovery time and improved post-operative mobility to drive adoption
  • 12.4.2 TIBIAL TUBEROSITY ADVANCEMENT (TTA)
    • 12.4.2.1 Increased success rates and reduced complication rates to support market growth
  • 12.4.3 EXTRACAPSULAR CCL REPAIR
    • 12.4.3.1 Cost-effective solutions with reliable outcomes to fuel market growth
  • 12.4.4 ARTHROSCOPY
    • 12.4.4.1 Minimally invasive techniques and faster recovery times to drive growth of arthroscopy

13 VETERINARY ORTHOPEDICS MARKET, BY END USER

• 13.1 INTRODUCTION
• 13.2 VETERINARY HOSPITALS & CLINICS
  • 13.2.1 EXPANDING ORTHOPEDIC PROCEDURE VOLUMES IN VETERINARY HOSPITALS & CLINICS TO DRIVE IMPLANT ADOPTION
• 13.3 SPECIALTY ORTHOPEDIC CLINICS
  • 13.3.1 RISING REFERRAL COMPLEXITY AT SPECIALTY ORTHOPEDIC CLINICS TO ACCELERATE USE OF ADVANCED FIXATION SYSTEMS
• 13.4 EMERGENCY ANIMAL HOSPITALS
  • 13.4.1 INCREASING TRAUMA CASELOADS IN EMERGENCY ANIMAL HOSPITALS TO BOOST DEMAND FOR RAPID STABILIZATION SOLUTIONS
• 13.5 ACADEMIC & RESEARCH INSTITUTES
  • 13.5.1 ACADEMIC & RESEARCH INSTITUTES TO ADVANCE ORTHOPEDIC INNOVATION THROUGH CLINICAL TRAINING AND VALIDATION
• 13.6 ANIMAL REHABILITATION CENTERS
  • 13.6.1 GROWING INTEGRATION OF ANIMAL REHABILITATION CENTERS TO STRENGTHEN LONG-TERM ORTHOPEDIC CARE PATHWAYS

14 VETERINARY ORTHOPEDICS MARKET, BY REGION

• 14.1 INTRODUCTION
• 14.2 GLOBAL VOLUME ANALYSIS FOR VETERINARY ORTHOPEDICS MARKET, 2024-2031
• 14.3 NORTH AMERICA
  • 14.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 14.3.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024-2031 (THOUSAND UNITS)
  • 14.3.3 NORTH AMERICA: VOLUME ANALYSIS, BY MATERIAL, 2024-2031 (THOUSAND UNITS)
  • 14.3.4 US
    • 14.3.4.1 Rising pet population to drive demand for veterinary orthopedic equipment
  • 14.3.5 CANADA
    • 14.3.5.1 Rising pet adoption rate to drive market
• 14.4 EUROPE
  • 14.4.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 14.4.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024-2031 (THOUSAND UNITS)
  • 14.4.3 EUROPE: VOLUME ANALYSIS, BY MATERIAL, 2024-2031 (THOUSAND UNITS)
  • 14.4.4 GERMANY
    • 14.4.4.1 Germany to dominate European market
  • 14.4.5 UK
    • 14.4.5.1 Increasing pet ownership to drive market growth
  • 14.4.6 FRANCE
    • 14.4.6.1 Rising veterinary healthcare expenditure to drive market
  • 14.4.7 ITALY
    • 14.4.7.1 Growing livestock population and rising awareness to support market growth
  • 14.4.8 SPAIN
    • 14.4.8.1 Rising animal population to drive market growth
  • 14.4.9 NETHERLANDS
    • 14.4.9.1 Large pet population to fuel market growth
  • 14.4.10 REST OF EUROPE
• 14.5 ASIA PACIFIC
  • 14.5.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 14.5.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT, 2024-2031 (THOUSAND UNITS)
  • 14.5.3 ASIA PACIFIC: VOLUME ANALYSIS, BY MATERIAL, 2024-2031 (THOUSAND UNITS)
  • 14.5.4 CHINA
    • 14.5.4.1 China to dominate APAC market
  • 14.5.5 JAPAN
    • 14.5.5.1 Rising demand for imported breeds to drive market
  • 14.5.6 INDIA
    • 14.5.6.1 Rising livestock population and growing awareness to boost market growth
  • 14.5.7 AUSTRALIA
    • 14.5.7.1 Rising livestock animal population and increasing pet ownership to support market growth
  • 14.5.8 SOUTH KOREA
    • 14.5.8.1 Increasing demand for preventive care and aging pet population to drive market
  • 14.5.9 THAILAND
    • 14.5.9.1 Increasing companion animal population to boost market growth
  • 14.5.10 NEW ZEALAND
    • 14.5.10.1 Large pet population to increase demand for orthopedic products
  • 14.5.11 REST OF ASIA PACIFIC
• 14.6 LATIN AMERICA
  • 14.6.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 14.6.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024-2031 (THOUSAND UNITS)
  • 14.6.3 LATIN AMERICA: VOLUME ANALYSIS, BY MATERIAL, 2024-2031 (THOUSAND UNITS)
  • 14.6.4 BRAZIL
    • 14.6.4.1 Brazil to dominate LATAM market due to large companion animal population
  • 14.6.5 MEXICO
    • 14.6.5.1 Rising demand for animal-derived food products to contribute to market growth
  • 14.6.6 REST OF LATIN AMERICA
• 14.7 MIDDLE EAST & AFRICA
  • 14.7.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 14.7.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT, 2024-2031 (THOUSAND UNITS)
  • 14.7.3 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY MATERIAL, 2024-2031 (THOUSAND UNITS)
  • 14.7.4 GCC COUNTRIES
    • 14.7.4.1 Kingdom of Saudi Arabia (KSA)
      • 14.7.4.1.1 Technology advancements in veterinary orthopedics to boost growth
    • 14.7.4.2 United Arab Emirates (UAE)
      • 14.7.4.2.1 Government support and high livestock population to fuel UAE's market growth
    • 14.7.4.3 Rest of GCC Countries
  • 14.7.5 REST OF MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE

• 15.1 OVERVIEW
• 15.2 KEY PLAYER STRATEGY/RIGHT TO WIN
• 15.3 REVENUE ANALYSIS, 2021-2025
• 15.4 MARKET SHARE ANALYSIS, 2025
  • 15.4.1 US MARKET SHARE ANALYSIS, 2025
  • 15.4.2 EUROPE MARKET SHARE ANALYSIS, 2025
  • 15.4.3 RANKING OF KEY MARKET PLAYERS
• 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 15.5.1 STARS
  • 15.5.2 EMERGING LEADERS
  • 15.5.3 PERVASIVE PLAYERS
  • 15.5.4 PARTICIPANTS
  • 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 15.5.5.1 Company footprint
    • 15.5.5.2 Region footprint
    • 15.5.5.3 Product footprint
    • 15.5.5.4 Application footprint
    • 15.5.5.5 Animal type footprint
• 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 15.6.1 PROGRESSIVE COMPANIES
  • 15.6.2 RESPONSIVE COMPANIES
  • 15.6.3 DYNAMIC COMPANIES
  • 15.6.4 STARTING BLOCKS
  • 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 15.6.5.1 Detailed list of key startups/SMEs
    • 15.6.5.2 Competitive benchmarking of key startups
• 15.7 BRAND/PRODUCT COMPARISON
• 15.8 R&D EXPENDITURE OF KEY PLAYERS
• 15.9 COMPANY VALUATION & FINANCIAL METRICS
  • 15.9.1 FINANCIAL METRICS
  • 15.9.2 COMPANY VALUATION
• 15.10 COMPETITIVE SCENARIO
  • 15.10.1 PRODUCT LAUNCHES
  • 15.10.2 DEALS
  • 15.10.3 EXPANSIONS
  • 15.10.4 OTHER DEVELOPMENTS

16 COMPANY PROFILES

• 16.1 KEY PLAYERS
  • 16.1.1 MOVORA
    • 16.1.1.1 Business overview
    • 16.1.1.2 Products offered
    • 16.1.1.3 Recent developments
      • 16.1.1.3.1 Deals
      • 16.1.1.3.2 Expansions
    • 16.1.1.4 MnM view
      • 16.1.1.4.1 Key strengths
      • 16.1.1.4.2 Strategic choices
      • 16.1.1.4.3 Weaknesses & competitive threats
  • 16.1.2 SECUROS SURGICAL (CENCORA, INC.)
    • 16.1.2.1 Business overview
    • 16.1.2.2 Recent developments
      • 16.1.2.2.1 Other developments
    • 16.1.2.3 MnM view
      • 16.1.2.3.1 Key strengths
      • 16.1.2.3.2 Strategic choices
      • 16.1.2.3.3 Weaknesses & competitive threats
  • 16.1.3 DEPUY SYNTHES (JOHNSON & JOHNSON)
    • 16.1.3.1 Business overview
    • 16.1.3.2 Products offered
    • 16.1.3.3 Recent developments
      • 16.1.3.3.1 Other developments
    • 16.1.3.4 MnM view
      • 16.1.3.4.1 Key strengths
      • 16.1.3.4.2 Strategic choices
      • 16.1.3.4.3 Weaknesses & competitive threats
  • 16.1.4 ARTHREX, INC.
    • 16.1.4.1 Business overview
    • 16.1.4.2 Products offered
    • 16.1.4.3 Recent developments
      • 16.1.4.3.1 Product launches
      • 16.1.4.3.2 Other developments
    • 16.1.4.4 MnM view
      • 16.1.4.4.1 Key strengths
      • 16.1.4.4.2 Strategic choices
      • 16.1.4.4.3 Weaknesses & competitive threats
  • 16.1.5 ORTHOMED (UK) LTD.
    • 16.1.5.1 Business overview
    • 16.1.5.2 Products offered
    • 16.1.5.3 Recent developments
      • 16.1.5.3.1 Product launches
      • 16.1.5.3.2 Deals
      • 16.1.5.3.3 Other developments
    • 16.1.5.4 MnM view
      • 16.1.5.4.1 Key strengths
      • 16.1.5.4.2 Strategic choices
      • 16.1.5.4.3 Weaknesses & competitive threats
  • 16.1.6 B. BRAUN SE
    • 16.1.6.1 Business overview
    • 16.1.6.2 Products offered
  • 16.1.7 VETERINARY INSTRUMENTATION
    • 16.1.7.1 Business overview
    • 16.1.7.2 Products offered
  • 16.1.8 ANTECH DIAGNOSTICS, INC.
    • 16.1.8.1 Business overview
    • 16.1.8.2 Products offered
    • 16.1.8.3 Recent developments
      • 16.1.8.3.1 Deals
  • 16.1.9 RITA LEIBINGER GMBH & CO. KG
    • 16.1.9.1 Business overview
    • 16.1.9.2 Products offered
    • 16.1.9.3 Recent developments
      • 16.1.9.3.1 Deals
  • 16.1.10 BLUESAO
    • 16.1.10.1 Business overview
    • 16.1.10.2 Products offered
  • 16.1.11 INTEGRA LIFESCIENCES CORPORATION
    • 16.1.11.1 Business overview
    • 16.1.11.2 Products offered
  • 16.1.12 INTRAUMA S.P.A
    • 16.1.12.1 Business overview
    • 16.1.12.2 Products offered
  • 16.1.13 SURGICAL HOLDINGS VETERINARY
    • 16.1.13.1 Business overview
    • 16.1.13.2 Products offered
    • 16.1.13.3 Recent developments
      • 16.1.13.3.1 Deals
  • 16.1.14 PH ORTHCOM
    • 16.1.14.1 Business overview
    • 16.1.14.2 Products offered
  • 16.1.15 GERVETUSA
    • 16.1.15.1 Business overview
    • 16.1.15.2 Products offered
• 16.2 OTHER PLAYERS
  • 16.2.1 NARANG MEDICAL LIMITED
  • 16.2.2 FUSION IMPLANTS
  • 16.2.3 BIO3DTECH
  • 16.2.4 ORTHOMAX MFG. CO. PVT. LTD.
  • 16.2.5 VET ORTHOPEDICS
  • 16.2.6 WELL TRUST (TIANJIN) TECH CO., LTD.
  • 16.2.7 VETERINARYIMPLANTS.COM (VETERINARY DIVISION OF GPC MEDICAL LTD.)
  • 16.2.8 INVICTOS
  • 16.2.9 SAFEX INC.
  • 16.2.10 GSOURCE (ARCH MEDICAL SOLUTIONS)

17 RESEARCH METHODOLOGY

• 17.1 RESEARCH DATA
• 17.2 RESEARCH METHODOLOGY DESIGN
  • 17.2.1 SECONDARY DATA
    • 17.2.1.1 Key data from secondary sources
  • 17.2.2 PRIMARY DATA
    • 17.2.2.1 Key data from primary sources
    • 17.2.2.2 Key industry insights
• 17.3 MARKET SIZE ESTIMATION
  • 17.3.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
  • 17.3.2 APPROACH 2: COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 17.3.3 APPROACH 3: DEMAND-SIDE ANALYSIS
  • 17.3.4 TOP-DOWN APPROACH
  • 17.3.5 BOTTOM-UP APPROACH
• 17.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 17.5 MARKET SHARE ESTIMATION
  • 17.5.1 RESEARCH ASSUMPTIONS
  • 17.5.2 GROWTH RATE ASSUMPTIONS
• 17.6 RISK ASSESSMENT
• 17.7 RESEARCH LIMITATIONS
  • 17.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 17.7.2 SCOPE-RELATED LIMITATIONS

18 APPENDIX

• 18.1 DISCUSSION GUIDE
• 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 18.3 CUSTOMIZATION OPTIONS
  • 18.3.1 PRODUCT ANALYSIS
  • 18.3.2 COMPANY INFORMATION
  • 18.3.3 GEOGRAPHIC ANALYSIS
  • 18.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
  • 18.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT TYPE
  • 18.3.6 MARKET SHARE ANALYSIS, BY PRODUCT (TOP 5 PLAYERS)
  • 18.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
• 18.4 RELATED REPORTS
• 18.5 AUTHOR DETAILS